Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract


  • Jack L. Gluckman M.D.,

    Corresponding author
    1. Department of Otolaryngology and Maxillofacial Surgery, University of Cincinnati Medical Center, Cincinnati, OH
    • Department of Otolaryngology, University of Cincinnati Medical Center, 231 Bethesda Ave., Cincinnati, OH 45267
    Search for more papers by this author
  • John D. Crissman M.D.

    1. The Department of Pathology, Wayne State University and Harper-Grace Hospitals, Detroit, MI
    Search for more papers by this author

  • Presented at the 85th Annual Meeting of the American Laryngological, Rhinological and Otological Society, Inc., Palm Beach, FL, May 6, 1982.


The high incidence of multiple primary carcinomas occurring in the upper aerodigestive tract is well documented, with the accepted incidence being as high as 20–30%. The full clinical significance of this phenomenon is, however, only now becoming apparent. Herein 548 cases of documented multiple primary neoplasms, presenting initially in the upper aerodigestive tract, are evaluated retrospectively to establish the survival in these patients. The overall 5 year survival rate after diagnosis of the second neoplasm was found to be 22.3% which was significantly lower than a control group.

The reasons for this poor survival are considered. These include: 1. the high incidence of second cancers developing in the lung and esophagus which have an extremely poor survival rate; 2. the frequent late diagnosis of the second lesions, with resultant advanced staging, and therefore poor prognosis; 3. inability to institute the appropriate therapy for these lesions due to the effects of previous radical therapy utilized for the first tumor.

The clinical implications of this problem are discussed.